Skip to next slide
You can skip to the next slide in
3
Ad
Skip to next slide
You can skip to the next slide in
3
Ad
Skip to next slide
You can skip to the next slide in
3
Ad
Skip to next slide
You can skip to the next slide in
3
Ad
Skip to next slide
You can skip to the next slide in
3
Ad
Skip to next slide
You can skip to the next slide in
3
Ad
Skip to next slide
You can skip to the next slide in
3
Ad
Skip to next slide
You can skip to the next slide in
3
Ad
Skip to next slide
You can skip to the next slide in
3
Ad
Skip to next slide
You can skip to the next slide in
3
Ad
Skip to next slide
You can skip to the next slide in
3
Ad
×
Your browser does not support the video tag.
Skip to next slide
Ad
×
Advertisement
Advertisement
Share Slideshare
LinkedIn
Facebook
Twitter
Embed
Size (px)
Show related Slideshows at end
WordPress Shortcode
Link
Share
Email
2024 Trend Updates: What Really Wor...
by Search Engine Jou...
1063677 views
Storytelling For The Web: Integrate...
by Chiara Aliotta
982505 views
Artificial Intelligence, Data and C...
by OECD Directorate ...
924689 views
How to Leverage AI to Boost Employe...
by SocialHRCamp
392956 views
2024 State of Marketing Report – by...
by Marius Sescu
222263 views
Everything You Need To Know About C...
by Expeed Software
237949 views
View on Slideshare
1
of
12
Ad
View on Slideshare
1
of
12
Ad
![see Table 1, Charts 1-3 [11]. The visualization shows that some drugs are receiving unprecedented
attention: e.g., pregaba...](https://image.slidesharecdn.com/remediaavailabilityinczechencz-200118123644/85/How-is-the-situation-concerning-drug-availability-in-the-Czech-Republic-CZ-EN-7-320.jpg?cb=1579351207)
![Literature
[1] Zákon378/2007Sb., oléčivech, §3a, odst. 10.
[2] Zákon 378/2007 Sb., o léčivech, § 33.
[3] Zákon 378/2007 Sb...](https://image.slidesharecdn.com/remediaavailabilityinczechencz-200118123644/85/How-is-the-situation-concerning-drug-availability-in-the-Czech-Republic-CZ-EN-12-320.jpg?cb=1579351207)